A Service For Professionals Sunday, August 20, 2017
Contact (202) 540-8337

Company News Today

A Service For Professionals Sunday, August 20, 2017 11435 Sources 399,152,674 Articles 3,328,029 Readers
Contact (202) 540-8337

NaturalNano To Build On Successes With Research Programs

October 14, 2009 (FinancialWire) — NaturalNano, Inc. (OTCBB: NNAN) (Frankfurt: N3N) acting CEO and president James Wemett said the company is taking a more aggressive approach to supplying Halloysite samples to researchers.

“We are changing the way we have been providing samples for research and feasibility studies. In the past, we have been supplying samples at a nominal cost; however, going forward, the company will make small quantity samples available to Researchers on a cost-free basis to encourage them to more actively assess the benefits of the NaturalNano’s Halloysite Natural Tubes,” Wernet said.

The NaturalNano decision is driven by a number of recent successes in feasibility studies which were significantly enhanced by the use of HNT in a variety of applications. NaturalNano recently announced a successful collaboration with Professor Michael King, Ph.D., of the Department of Biomedical Engineering at Cornell University in Ithaca, NY, who successfully incorporated using our Halloysite Natural Tubes to enhance the capture of cancer cells while being non-toxic to cancer cells. These experimental devices hold the potential for reducing or eliminating metastatic disease, the secondary spread of cancer beyond the initial tumor site. The King study and the role played by the HNT are described in an article available at http://www.news.cornell.edu/stories/June09/GeneTherapy.html.

Wemett added, “University innovation is the key to growing our economy and NaturalNano wants to encourage innovation and identify additional uses for HNT. This effort will accelerate commercialization. We at NaturalNano will benefit by potentially being a supplier once the technology is commercialized, and by being first in line to license technology.”

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Powered by EIN Presswire